ZBH Zimmer Biomet Holdings, Inc.

101.47USD-1.79%Mkt Cap: 19.20B USDP/E: 25.62

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip pr…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap19.20B USD
Enterprise Value26.79B USD
Revenue (TTM)8.57B USD
Gross Profit5.74B USD
Net Income (TTM)705.10M USD
Revenue/Share44.24 USD
Last Price101.47 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees17.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)25.62
P/E (Forward)11.32
PEG2.21
EV/EBITDA10.54
EV/Revenue3.13
P/S2.24
P/B1.52
EPS (TTM)3.96 USD
EPS (Forward)8.98 USD
52W Range
79.1267% of range112.54
52W High112.54 USD
52W Low79.12 USD
Profitability
Gross Margin69.71%
Oper. Margin16.74%
EBITDA Margin29.65%
Profit Margin8.57%
ROE5.55%
ROA3.05%
ROIC5.86%
ROCE6.61%
Growth
Revenue Growth3.10%
Earnings Growth-13.80%
Cash Flow & Leverage
Operating CF1.70B USD
CapEx (TTM)276.90M USD
FCF Margin16.83%
FCF Yield7.51%
Net Debt7.23B USD
Net Debt/EBITDA2.85
Net Debt/FCF5.01
Balance Sheet
Debt/Equity0.59
Current Ratio1.46
Quick Ratio0.64
Book Value/Sh66.89 USD
Cash/Share2.26 USD
Dividends
Fwd Div Rate0.96 USD
Trail. Div Rate0.96 USD
Div. Yield0.93%
5Y Avg Yield0.87%
Payout Ratio24.24%
Ex-Div DateSep 30, 2026
Pay DateOct 30, 2026
Splits
Last Split103:100
Split DateMar 1, 2022
Analyst Consensus
Rating2.4 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)117.38 USD
Upside (mean)+15.7%
Target Range98.00 USD – 140.00 USD
98.00+15.7% to mean140.00
# Analysts21
Ownership
Shares Out.189.25M
Float188.64M
Insiders0.14%
Institutions103.94%
Short Interest
Short Ratio3.8d
Short % Float5.49%
Short % Out.4.15%
Shares Short7.85M
Short (prev mo.)9.75M
Technical
SMA 5095.83 (+5.9%)
SMA 20092.60 (+9.6%)
Beta0.47
S&P 52W Chg12.08%
Avg Vol (30d)2.28M
Avg Vol (10d)2.85M
Technical Indicators
RSI (14)51.8
MACD2.0638
MACD Signal2.5782
MACD Hist.-0.5144
BB Upper111.38 USD
BB Middle101.83 USD
BB Lower92.29 USD
BB Width18.75%
ATR (14)3.237 USD
Vol Ratio (20d)0.71x

About Zimmer Biomet Holdings (NYSE: ZBH)

›

Zimmer Biomet Holdings (NYSE: ZBH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 17,000 employees.

The shares were at 101.47 USD on 19 November 2026, up 13.5% over 52 weeks. Its 52-week range is 79.12 USD to 112.54 USD: the price is 9.8% below the high and 28.2% above the low.

At a market capitalisation of 19.20B USD, it trades at 25.6 times trailing earnings and 11.3 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.4, so ZBH is valued in line with them. It pays a dividend yielding 0.93% (it pays out 24% of its earnings), against a median of 2.41% among the dividend payers in that peer group.

Zimmer Biomet Holdings reports return on equity of 5.6%, an operating margin of 16.7% and revenue up 3.1% year over year.

Its debt exceeds its cash by 7.23B USD, a debt-to-equity ratio of 0.59. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 21 analysts cover the stock, with an average rating of Buy; their mean price target of 117.38 USD is 15.7% above the current price. The next earnings report is expected on 10 February 2027.